Melt in Your Body, Not in a Needle: A Review of ADF Opioids

Challenge accepted. Our country has made numerous strides in advancing patient care, and more particularly conducting efforts to ensure that lives within the national opioid crisis are saved and/or improved. One of those positive strides involves the FDA approval of abuse-deterrent formulation (ADF) opioid medications, with the aim of preventing the transition from the misuse and/or abuse of prescription opioid medications to illicit (and possibly laced) diacetylmorphine (aka, heroin). How do these formulations work? What ADF opioid medications are not only specifically approved as an ADF opioid medication, but also available on the US market? Are these ADFs really foolproof? The street chemists of our country have already accepted the challenge to be knowledgeable on all of the above and now it’s our turn as healthcare professionals to get up to speed on these risk reduction entities.

Additional Information

AttachmentSize
PDF icon Slides and disclosures7.33 MB
Course summary
Available credit: 
  • 1.00 AAFP
  • 1.00 AANP
  • 1.00 ACCME (All Other)
  • 1.00 ACCME (MD/DO Only)
  • 1.00 ACPE Pharmacy
  • 1.00 ANCC
  • 1.00 APA
Course opens: 
06/01/2021
Course expires: 
06/01/2022
Rating: 
0

Available Credit

  • 1.00 AAFP
  • 1.00 AANP
  • 1.00 ACCME (All Other)
  • 1.00 ACCME (MD/DO Only)
  • 1.00 ACPE Pharmacy
  • 1.00 ANCC
  • 1.00 APA
Please login or register to take this course.

Required Hardware/software

A computer with an internet connection
Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
Other additional software may be required such as PowerPoint or Adobe Acrobat Reader.